Stop-Loss Rates Are SKYROCKETING – And Trump’s Drug Policy Is Shaking Things Up

Rates for stop-loss policies are zooming up at breakneck speed. While the reasons are multifold—a recent surge in unpredictable high-cost claims, medical inflation, soaring demand for specialty drugs—and largely uncontrollable, the stewards of self-funded health plans need to start looking at cost containment solutions, which are in their control. It’s a timely and loaded subject, one that, along with President Trump’s new 100 percent tariff on certain imported drugs, will be at the heart of Phia’s webinar.